can you take semaglutide with crohn's disease GLP-1 Use in Disease: Safety & IBD Considerations – PlexusDx 5 Things Not to Say

These impacts are especially noticeable in the first four to eight weeks of a patients GLP-1 weight loss journey, leading to issues like constipation, nausea, bloating, vomiting, and other gastrointestinal discomforts

Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist, while Tirzepatide (Mounjaro, Zepbound) binds with both receptors (GLP-1 and GIP) and thus tends to have more effects on weight loss than semaglutide alone

doi: 10.1007/s00774-011-0321-5

500K users track GLP-1 with MeAgain, and the app holds 4.8 stars across 25K App Store ratings grocery choices sit beside dose timing, side effects, and weight, where they actually make sense.

However, I still think that the genetic testing can be very useful in the patients who has complex chronic disease